Equillium, Inc. (EQ) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $111 million, Equillium, Inc. is a micro-cap company. The stock currently trades at $1.77, down 7.69% today, with a 52-week range of $0.27–$2.35.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.23 | $-0.23 | +39.5% | |
| 2023 | $-0.38 | $-0.38 | +79.5% | |
| 2022 | $-1.85 | $-1.85 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-27 | 0000950170-25-045726 | SEC ↗ |
| 2023-12-31 | 2024-03-25 | 0000950170-24-035919 | SEC ↗ |
| 2022-12-31 | 2023-03-23 | 0000950170-23-009492 | SEC ↗ |
| 2021-12-31 | 2022-03-23 | 0000950170-22-004407 | SEC ↗ |
| 2020-12-31 | 2021-03-24 | 0001564590-21-015103 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001564590-20-013207 | SEC ↗ |
| 2018-12-31 | 2019-03-27 | 0001564590-19-009580 | SEC ↗ |